The Board Membership team at Palleon Pharmaceuticals provides strategic oversight, governance, and expert guidance to ensure the company's mission of developing Glyco-Immune Checkpoint inhibitors for cancer treatment is successfully achieved. Members bring diverse insights and maintain accountability to stakeholders, driving forward the company's objectives with integrity and vision.